Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best MK-677 Dosage for Appetite: Research Application Comparison

Cachexia/Wasting Models 12.5–15mg daily Appetite increase within 48–72 hours; stabilizes week 2–3 Minimal if baseline glucose <100 mg/dL Lowest effective dose for appetite without GH-driven metabolic effects Anabolic Surplus Support 20–25mg daily Noticeable hu

This comparison does not assign a generated winner or score.

  • Cachexia/Wasting Models
  • 12.5–15mg daily
  • Appetite increase within 48–72 hours; stabilizes week 2–3
  • Minimal if baseline glucose <100 mg/dL
  • Lowest effective dose for appetite without GH-driven metabolic effects
  • Anabolic Surplus Support
  • 20–25mg daily
  • Noticeable hunger day 3–5; meal frequency increases week 2
  • Fasting glucose may rise 5–10 mg/dL transiently
  • Balances appetite stimulation with growth hormone output for lean mass studies
  • GH Pulsatility Research
  • 25mg daily
  • GH pulse amplitude increases within 7 days; IGF-1 peaks week 4–6
  • Moderate. Monitor fasting and postprandial glucose closely
  • Maximum GH output; appetite is secondary but pronounced
  • Geriatric Appetite Decline
  • 10–12.5mg daily
  • Gradual appetite normalization over 10–14 days
  • Lowest risk profile for insulin-sensitive populations
  • Conservative dose appropriate for age-related metabolic vulnerability
More references

Related material